·s«a¯f¬r¼ç¥ñ´Á ¤@¦¨¶W14¤Ñ
¡i©ú³ø±M°T¡jÂå¾Ç¬ã¨s½×¤å¹w¦L¥»µo¥¬¥¥x¡umedRxiv¡v10¤éµoªí¤F¥_¨Ê¤j¾Ç¹Î¶¤»P¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¦@¦P´£¥XªºÃö©ó·s«¬«aª¬¯f¬r¯e¯f(COVID-19)¼ç¥ñ´Áªº·s¬ã¨s¡C
¬ã¨s¹Î¶¤«ü¥X¡A¹B¥Î·§²v¾Ç¤¤ª¾¦Wªº§ó·s²z½×¶i¦æ¦ôp¡Aµo²{·s«aªÍª¢¯f¬rªº¼ç¥ñ´Á¥i¯à¤ñ¤wª¾ªº14¤Ñ§óªø¡A¤j¬ù¤@¦¨ªº±wªÌ¼ç¥ñ´Áªø©ó14¤Ñ¡C
¸Ó¬ã¨s³ø§iªº§@ªÌ¹Î¶¤¨Ó¦Û¥_¨Ê¤j¾Ç¤½¦@½Ã¥Í¾Ç°|¡B¥_¨Ê°ê»Ú¼Æ¾Ç¬ã¨s¤¤¤ß¡B¤¤°ê¯e¯f¹w¨¾±±¨î¤¤¤ß¡B¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¤UÄݪº°ê®a¹L±Ó¯g©M¶Ç¬V¯f¬ã¨s©Ò(NIAID)µ¥¡A¸Ó¹Î¶¤ªí¥Ü¡A¾¨ºÞ¤w¸g¦³«Ü¦h¬ÛÃö¬ã¨s¡A¦ý¹ï·s«a¯f¬r³Ì«nªºÁ{þH¯S¼x¤§¤@¡u¼ç¥ñ´Á¡vªº¤À§G©|¤£²M·¡¡A¦b³o¶µ¬ã¨s¤¤¡A¸Ó¹Î¶¤´£¥X¤@ºØ·sªº§C¦¨¥»¡B§ó·Ç½Tªº¤èªk¨Ó¦ôp¼ç¥ñ´Á¤À§G¡A¦¬¶°¤F1211¨Ò±wªÌ¸ê°T¡A¬O¥Ø«e¤wª¾Ãö©ó·s«a¯e¯f¼ç¥ñ´Á¬ã¨s¤¤¼Ë¥»¶q³Ì¤jªº¡C
¬ã¨sµo²{¡A·s«a¯f¬r¼ç¥ñ´Áªº¦ôp¤¤¦ì®É¶¡¬°8.13¤Ñ¡A¥§¡®É¶¡¬°8.62¤Ñ¡A±N¼ç¥ñ´Á®É¶¡±qµu¨ìªø±Æ¦C¨Ã¥Î¦Ê¤À¤ñªí¥Üªº¸Ü¡A²Ä90ӦʤÀÂI¬O14.65¤Ñ¡A¥Nªí¤j¬ù10%ªº·s«¬«aª¬¯f¬r±wªÌ·P¬V«á14¤Ñ¤~·|¥X²{¯gª¬¡C
¸Ó¹Î¶¤«ü¥X¡A»P¨ä¥L¬ã¨sµ²ªG¬Û¤ñ¡A¥»¬ã¨s¦ôpªº·s«a¯f¬r¼ç¥ñ´Á§óªø¡A¹Î¶¤»{¬°»Ýn¹ï¼ç¥ñ´Á¤À¥¬¶i¦æ¶i¤@¨B¬ã¨s¡A¤~¯àª½±µ¦ôp¼ç¥ñ´Á¸ûªøªº±wªÌ©Ò¦û¤ñ¨Ò¡AY¹ï¼ç¥ñ´Á®É¶¡¦³§ó·Ç½T¤F¸Ñ¡A±N¦³§U©ó·s«a¯f¬r¯e¯f±±¨î´£¨Ñ³Ì¨Îªº¹jÂ÷´Á®É¶¡¡A¨Ã¥B¦b¬ã¨s¯e¯f¶Ç¼½©Mµo®i¾÷¨î¤è±µo´§§@¥Î¡C